Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T N Campbell

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biotechniques|February 24, 2001
Large-scale colony screening and insert orientation determination using PCRT N Campbell, F Y Choy
Cancer Treatment Reports|September 1, 1982
High-dose allopurinol modulation of 5-FU toxicity: phase I trial of an outpatient dose scheduleT N Campbell, S B Howell, C Pfeifle, et al.
Biochemical and Biophysical Research Communications|October 7, 2006
Ephrin A5 expression promotes invasion and transformation of murine fibroblastsT N Campbell, S Attwell, M Arcellana-Panlilio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1983
Clinical pharmacokinetics of intraarterial cisplatin in humansT N Campbell, S B Howell, C E Pfeifle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3J C Gutheil, T N Campbell, P R Pierce, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1984
Alternating combination chemotherapy for stages III and IV ovarian carcinomaJ A Young, A Johnson, J Kroener, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biotechniques|February 24, 2001
Large-scale colony screening and insert orientation determination using PCRT N Campbell, F Y Choy
Cancer Treatment Reports|September 1, 1982
High-dose allopurinol modulation of 5-FU toxicity: phase I trial of an outpatient dose scheduleT N Campbell, S B Howell, C Pfeifle, et al.
Biochemical and Biophysical Research Communications|October 7, 2006
Ephrin A5 expression promotes invasion and transformation of murine fibroblastsT N Campbell, S Attwell, M Arcellana-Panlilio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1983
Clinical pharmacokinetics of intraarterial cisplatin in humansT N Campbell, S B Howell, C E Pfeifle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3J C Gutheil, T N Campbell, P R Pierce, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1984
Alternating combination chemotherapy for stages III and IV ovarian carcinomaJ A Young, A Johnson, J Kroener, et al.
Pageof 1